Why is Linezolid banned in China?
Linezolid (Linezolid) is not completely banned in China, but is strictly controlled due to its specificity and potential side effects. Many patients mistakenly believe that "linezolid is banned", which is actually a misunderstanding of its restricted use policy.
First of all, linezolid has long been approved for marketing in China and is widely used in the clinical treatment of drug-resistant bacterial infections (bacterial infections). However, it belongs to the "special use grade antibacterial drugs" under national key monitoring, which means that it must be used under strict indications and prescription authority, and cannot be prescribed by non-professional doctors or non-designated departments at will. The hospital pharmacy committee usually develops a special approval process to ensure its reasonable use.

Secondly, the safety risk of linezolid is an important reason for its restriction. Long-term use may lead to serious adverse reactions such as bone marrow suppression, lactic acidosis, optic nerve and peripheral nerve damage. These side effects are relatively rare in short-term use, but the risk increases significantly during long-term treatment. In order to avoid serious consequences caused by unreasonable use, China has strict requirements on the prescription and course length of linezolid.
In addition, pharmacoeconomic and public health perspectives have also motivated its restricted use. Linezolid is relatively expensive and, if widely used, may increase the financial burden on medical insurance and patients. At the same time, misuse may also accelerate the development of drug resistance and weaken its life-saving value in truly critical infections. Based on this consideration, China has included it in hierarchical management to ensure that drugs are used rationally in patients who really need them.
Therefore, the so-called "banned" actually means "strictly restricted" and does not mean that the drug itself has been removed from the shelves or completely discontinued. Linezolid is still an important weapon against drug-resistant infections in China, but it must be used rationally and under strict indications by professional doctors. In the future, linezolid's accessibility may increase as domestic generics become more popular and prices decline.
Reference materials:https://go.drugbank.com/drugs/DB00601
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)